DongKook Pharmaceutical Revenue

In the year 2024, DongKook Pharmaceutical had annual revenue of 812.17B KRW with 11.10% growth. DongKook Pharmaceutical had revenue of 210.93B in the quarter ending December 31, 2024, with 12.27% growth.

Revenue

812.17B

Revenue Growth

+11.10%

P/S Ratio

0.84

Revenue / Employee

718.10M

Employees

1,131

Market Cap

684.08B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	812.17B	81.17B	11.10%
Dec 31, 2023	730.99B	69.35B	10.48%
Dec 31, 2022	661.65B	67.45B	11.35%
Dec 31, 2021	594.19B	35.09B	6.28%
Dec 31, 2020	559.10B	76.82B	15.93%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
ALTEOGEN	102.85B
Yuhan	2,067.79B
SK Biopharmaceuticals	547.60B
HLB Co., Ltd.	68.13B
Peptron	3.15B
LigaChem Biosciences	125.90B

Revenue Rankings